Labcorp Holdings Files 8-K Report
Ticker: LH · Form: 8-K · Filed: Sep 23, 2024 · CIK: 920148
| Field | Detail |
|---|---|
| Company | Labcorp Holdings Inc. (LH) |
| Form Type | 8-K |
| Filed Date | Sep 23, 2024 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.10, $2,000,000,000, $650,000,000, $500,000,000, $850,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing, financials
Related Tickers: LH
TL;DR
Labcorp filed an 8-K, likely a material agreement or financial update.
AI Summary
On September 23, 2024, LABCORP HOLDINGS INC. filed an 8-K report. The filing indicates the company entered into a material definitive agreement and also includes financial statements and exhibits. No specific details regarding the agreement or financial figures were provided in the excerpt.
Why It Matters
This filing signals a significant event for Labcorp Holdings, potentially involving a new agreement or updated financial information that could impact investors.
Risk Assessment
Risk Level: low — The filing is a standard disclosure and does not contain information suggesting immediate risk.
Key Players & Entities
- LABCORP HOLDINGS INC. (company) — Registrant
- September 23, 2024 (date) — Date of Report
- 358 South Main Street, Burlington, North Carolina 27215 (location) — Principal executive offices
- 336-229-1127 (phone_number) — Registrant's telephone number
FAQ
What is the nature of the material definitive agreement entered into by LABCORP HOLDINGS INC.?
The provided excerpt does not specify the details of the material definitive agreement.
When was the 8-K report filed by LABCORP HOLDINGS INC.?
The 8-K report was filed on September 23, 2024.
What are the principal executive offices of LABCORP HOLDINGS INC.?
The principal executive offices are located at 358 South Main Street, Burlington, North Carolina 27215.
What is the telephone number for LABCORP HOLDINGS INC.?
The registrant's telephone number is 336-229-1127.
What items are covered in this 8-K filing?
This 8-K filing covers the entry into a material definitive agreement and includes financial statements and exhibits.
Filing Stats: 1,353 words · 5 min read · ~5 pages · Grade level 10.9 · Accepted 2024-09-23 16:18:59
Key Financial Figures
- $0.10 — nge on which registered Common Stock, $0.10 par value LH New York Stock Exchang
- $2,000,000,000 — uer issued, and the Company guaranteed, $2,000,000,000 in debt securities, consisting of $650,
- $650,000,000 — 0,000 in debt securities, consisting of $650,000,000 aggregate principal amount of 4.350% Se
- $500,000,000 — nior Notes due 2030 (the "2030 Notes"), $500,000,000 aggregate principal amount of 4.550% Se
- $850,000,000 — r Notes due 2032 (the "2032 Notes") and $850,000,000 aggregate principal amount of 4.800% Se
- $1,982.1 million — ring of the Notes will be approximately $1,982.1 million after deducting underwriting discounts
- $350 million — 4, its 3.600% Senior Notes due 2025 and $350 million of borrowings under its revolving credi
Filing Documents
- d844966d8k.htm (8-K) — 36KB
- d844966dex41.htm (EX-4.1) — 312KB
- d844966dex42.htm (EX-4.2) — 164KB
- d844966dex43.htm (EX-4.3) — 164KB
- d844966dex44.htm (EX-4.4) — 164KB
- d844966dex51.htm (EX-5.1) — 16KB
- g844966g0921033409606.jpg (GRAPHIC) — 2KB
- 0001193125-24-223695.txt ( ) — 1167KB
- lh-20240923.xsd (EX-101.SCH) — 3KB
- lh-20240923_lab.xml (EX-101.LAB) — 17KB
- lh-20240923_pre.xml (EX-101.PRE) — 11KB
- d844966d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. 4.1 Indenture, dated as of September 23, 2024, between Laboratory Corporation of America Holdings, as issuer, and U.S. Bank Trust Company, National Association, as trustee 4.2 First Supplemental Indenture, dated as of September 23, 2024, among Laboratory Corporation of America Holdings, as issuer, Labcorp Holdings Inc., as guarantor, and U.S. Bank Trust Company, National Association, as trustee, including the form of the 2030 Notes 4.3 Second Supplemental Indenture, dated as of September 23, 2024, among Laboratory Corporation of America Holdings, as issuer, Labcorp Holdings Inc., as guarantor, and U.S. Bank Trust Company, National Association, as trustee, including the form of the 2032 Notes 4.4 Third Supplemental Indenture, dated as of September 23, 2024, among Laboratory Corporation of America Holdings, as issuer, Labcorp Holdings Inc., as guarantor, and U.S. Bank Trust Company, National Association, as trustee, including the form of the 2034 Notes 4.5 Form of 2030 Global Note representing $650,000,000 aggregate principal amount of 4.350% Senior Notes due 2030 (contained in Exhibit 4.2) 4.6 Form of 2032 Global Note representing $500,000,000 aggregate principal amount of 4.550% Senior Notes due 2032 (contained in Exhibit 4.3) 4.7 Form of 2034 Global Note representing $850,000,000 aggregate principal amount of 4.800% Senior Notes due 2034 (contained in Exhibit 4.4) 5.1 Opinion of Hogan Lovells US LLP, regarding the legality of the Notes 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABCORP HOLDINGS INC. Registrant Date: September 23, 2024 By: /s/ SANDRA D. VAN DER VAART Sandra D. van der Vaart Executive Vice President, Chief Legal Officer and Secretary